Binary polymorphic cocrystals: an update on the available literature in the Cambridge Structural Database, including a new polymorph of the pharmaceutical 1:1 cocrystal theophylline–3,4-dihydroxybenzoic acid
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Binary polymorphic cocrystals: an update on the available literature in the Cambridge Structural Database, including a new polymorph of the pharmaceutical 1:1 cocrystal theophylline–3,4-dihydroxybenzoic acid
Authors
Keywords
-
Journal
Acta Crystallographica Section C-Structural Chemistry
Volume 74, Issue 6, Pages 715-720
Publisher
International Union of Crystallography (IUCr)
Online
2018-05-23
DOI
10.1107/s2053229618006861
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Cambridge Structural Database
- (2016) Colin R. Groom et al. Acta Crystallographica Section B-Structural Science Crystal Engineering and Materials
- Facts and fictions about polymorphism
- (2015) Aurora J. Cruz-Cabeza et al. CHEMICAL SOCIETY REVIEWS
- SHELXT– Integrated space-group and crystal-structure determination
- (2015) George M. Sheldrick Acta Crystallographica A-Foundation and Advances
- Crystal structure refinement withSHELXL
- (2015) George M. Sheldrick Acta Crystallographica Section C-Structural Chemistry
- Synthon Hierarchies in Crystal Forms Composed of Theophylline and Hydroxybenzoic Acids: Cocrystal Screening via Solution-Mediated Phase Transformation
- (2014) Dejan-Krešimir Bučar et al. CRYSTAL GROWTH & DESIGN
- Hydrogen bond synthon competition in the stabilization of theophylline cocrystals
- (2014) Bipul Sarma et al. CRYSTENGCOMM
- Polymorphism in cocrystals: a review and assessment of its significance
- (2014) Srinivasulu Aitipamula et al. CRYSTENGCOMM
- Conformational Polymorphism
- (2013) Aurora J. Cruz-Cabeza et al. CHEMICAL REVIEWS
- New Solid Forms of the Anti-HIV Drug Etravirine: Salts, Cocrystals, and Solubility
- (2013) Lalit Rajput et al. CRYSTAL GROWTH & DESIGN
- Polymorphic Co-crystals from Polymorphic Co-crystal Formers: Competition between Carboxylic Acid···Pyridine and Phenol···Pyridine Hydrogen Bonds
- (2013) Andreas Lemmerer et al. CRYSTAL GROWTH & DESIGN
- Pharmaceutical cocrystals and poorly soluble drugs
- (2012) Ranjit Thakuria et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- WinGXandORTEP for Windows: an update
- (2012) Louis J. Farrugia JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Synthon polymorphism and pseudopolymorphism in co-crystals. The 4,4′-bipyridine–4-hydroxybenzoic acid structural landscape
- (2011) Arijit Mukherjee et al. CHEMICAL COMMUNICATIONS
- Pharmaceutical cocrystals: An overview
- (2011) Ning Qiao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Polymorphs and Solvates of a Cocrystal Involving an Analgesic Drug, Ethenzamide, and 3,5-Dinitrobenzoic Acid
- (2010) Srinivasulu Aitipamula et al. CRYSTAL GROWTH & DESIGN
- Structure−Stability Relationships in Cocrystal Hydrates: Does the Promiscuity of Water Make Crystalline Hydrates the Nemesis of Crystal Engineering?
- (2010) Heather D. Clarke et al. CRYSTAL GROWTH & DESIGN
- Drug Substance and Former Structure Property Relationships in 15 Diverse Pharmaceutical Co-Crystals
- (2009) Mary K. Stanton et al. CRYSTAL GROWTH & DESIGN
- Using Cocrystals To Systematically Modulate Aqueous Solubility and Melting Behavior of an Anticancer Drug
- (2009) Christer B. Aakeröy et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Co-crystallisation of benzoic acid derivatives with N-containing bases in solution and by mechanical grinding: stoichiometric variants, polymorphism and twinning
- (2008) Signe Skovsgaard et al. CRYSTENGCOMM
- Mercury CSD 2.0– new features for the visualization and investigation of crystal structures
- (2008) Clare F. Macrae et al. JOURNAL OF APPLIED CRYSTALLOGRAPHY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started